Loxapinum

EUEMA:by INNUSDailyMed:LoxapineUSFDA:Loxapine N05AH01(WHO) AU:S4(Prescription only)BR:Class C1(Other controlled substances)US:℞-onlyEU:Rx-only 8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzoxazepine 1977-10-2Y 3964 205 DB00408N 3827Y LER583670J D02340Y CHEBI:50841N ChEMBL831Y DTXSID7023229 Interactive image Clc2ccc1Oc4c(/N=C‍‍‍‍‍‍​​​‍​​​​​​(\c1c2)N3CCN(C)CC3)cccc4 InChI=1S/C18H18ClN3O/c1-21-8-10-22(11-9-21)18-14-12-13(19)6-7-16(14)23-17-5-3-2-4-15(17)20-18/h2-7,12H,8-11H2,1H3YKey:XJGVXQDUIWGIRW-UHFFFAOYSA-NY Loxapine, sold under the brand namesLoxitaneandAdasuve(inhalationonly) among others, is atricyclicantipsychoticmedication used primarily in the treatment ofschizophreniaandbipolar disorder. It is a member of thedibenzoxazepineclass and structurally very similar toclozapine. Several researchers have argued that loxapine, initially classified as atypical antipsychotic, behaves as anatypical antipsychotic. Loxapine may be metabolized byN-demethylation toamoxapine, atricyclic antidepressant.